Medtech Insight Will Hold its First In3 EUROPE Early-Stage Medical Technology Investment and Partnering Conference on Sept. 20-21 in Brussels, Belgium.

NEWPORT BEACH, Calif. -- Medtech Insight, a division of Windhover Information Inc., has announced that it will expand its "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference series to attract young start-up companies as well as investors from outside of the United States. The conference, called In3 EUROPE, will be held on Sept. 20-21, 2005, at The Crowne Plaza Brussels City Centre Hotel in Brussels, Belgium. Medtech Insight's "Investment In Innovation" and specialty investment and partnering conferences have established a reputation as the premier forum for senior executives in the medical device, diagnostics, biotech and investment communities to preview promising early-stage medical technology companies in need of funding, acquisition and/or strategic partnership.

This two-day event will feature more than 50 emerging medical device start-ups from around the world that will present to an audience of over 400 senior executives, representing most of the leading investment and medical technology firms. The forum will consist of 10-minute presentations by a senior executive from the presenting company, followed immediately by one-on-one meetings with company representatives in private breakout rooms. Companies will present on a range of technologies for such high-growth segments of the medical technology industry as interventional cardiology, spinal and orthopedic surgery, drug delivery technology, and stroke management, among many others.

"Typically, 20% of the companies that present at our domestic In3 conferences are from outside of the U.S. and are mainly from Europe and Israel," reported Sharon O'Reilly, president and CEO of Medtech Insight. "We have had many requests to hold an In3 conference in Europe and look forward to this meeting, where we'll bring together the international investment community with some of the most exciting medical technologies being developed from around the world."

In3 Europe is a must-attend event for anyone interested in emerging medical technology coming out of Europe as well as the United States. To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, e-mail [e-mail], or visit the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html. Through April 29 only, attendees registering for the conference can save $500 off the $1,495 registration fee.

If you are interested specifically in early-stage vascular or musculoskeletal companies and technologies, attend one of Medtech Insight's upcoming focused specialty investment and partnering events: "In circulation: Strategic Partnering and Investing in Circulatory Medicine" will be held April 27 in Chicago, and will feature over 35 innovative privately held companies developing technologies in interventional cardiology, cardiac surgery, neurosurgery, stroke management and peripheral vascular surgery. The "IN SPINE & ORTHOPEDICS: Strategic Partnering and Investing in Musculoskeletal Technology" conference will be held Nov. 3-4 in North Dallas, Texas, and will feature over 50 promising early-stage orthopedics and spine companies seeking strategic partners and/or funding.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.